ENTA Next Earnings Date Notes

— Enanta Pharmaceuticals (ticker: ENTA) is a biotechnology company focused on discovering & developing small molecule therapeutics for viral infections, with particular emphasis on hepatitis B virus (HBV), respiratory syncytial virus (RSV), & SARS-CoV-2 (COVID-19). Rather than commercializing drugs themselves, they typically license their compounds to larger pharmaceutical partners for later-stage development & commercial sales, which impacts their revenue streams. For investors listening to the next earnings call, key business metrics to track include R&D spend (driven by ongoing clinical trials), progress updates on lead candidates in their pipeline (such as EDP-938 for RSV & EDP-514 for HBV), partnership/licensing revenues (especially from Abbott for their HIV franchise), & cash burn rate, as the company has yet to become profitable. Pipeline milestone achievements, regulatory feedback, & clinical trial enrollment rates are critical for gauging long-term potential. Ultimately, ENTA’s long-term success hinges on advancing clinical candidates to late-stage trials or commercialization, while maintaining sufficient cash runway to support development. Keep an eye out for management’s commentary on trial progress & any partnership updates on the upcoming earnings call. The next projected earnings date for ENTA is 5/11/2026 after close (stay tuned for a confirmed earnings date once announced).

ENTA Next Earnings Date FAQ

On this page we presented the ENTA Next Earnings Date information for Enanta Pharma along with recent past earnings dates. For Q1 of 2026, ENTA reported earnings of -0.420/share, with the earnings report taking place on 2/9/2026. For Q4 of 2025, ENTA reported earnings of -0.870/share, with the earnings report taking place on 11/17/2025. For Q3 of 2025, ENTA reported earnings of -0.850/share, with the earnings report taking place on 8/11/2025. For Q2 of 2025, ENTA reported earnings of -1.060/share, with the earnings report taking place on 5/12/2025. For Q1 of 2025, ENTA reported earnings of -1.050/share, with the earnings report taking place on 2/10/2025. Based on these past earnings dates, the projected next earnings date for ENTA is 5/11/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Enanta Pharma. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Enanta Pharma shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Enanta Pharma next earnings dates as well as any other stock out there in our coverage universe, to see when the next ENTA earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ENTA's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ENTA next earnings date.